UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000010773 |
|---|---|
| Receipt number | R000012598 |
| Scientific Title | A study of the level of ghrelin with liver disfunction patients |
| Date of disclosure of the study information | 2013/05/21 |
| Last modified on | 2015/06/18 20:58:48 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A study of the level of ghrelin with liver disfunction patients
Acronym
A study of the level of ghrelin with liver disfunction patients
Scientific Title
A study of the level of ghrelin with liver disfunction patients
Scientific Title:Acronym
A study of the level of ghrelin with liver disfunction patients
Region
| Japan |
Condition
Condition
cirrhosis, chronic hepatitis
Classification by specialty
| Gastrointestinal surgery |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the ghrelin in liver disfunction patients
Basic objectives2
Others
Basic objectives -Others
Relationship between liver function and ghrelin
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
ghrelin level, liver function
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 80 | years-old | > |
Gender
Male and Female
Key inclusion criteria
1)patients with liver disfunction
2)Age>20 and <80 years
3)written informed consent
Key exclusion criteria
judged as inappropriate by physician-in-charge
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Yuichiro Doki |
Organization
Osaka University School of Medicine
Division name
Gastroenterological Surgery
Zip code
Address
2-2 Yamadaoka Suita City Osaka
TEL
06-6879-3251
ydoki@gesurg.med.osaka-u.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Murakakami Kohei |
Organization
Osaka University School of Medicine
Division name
Gastroenterological Surgery
Zip code
Address
2-2 Yamadaoka Suita City Osaka
TEL
06-6879-3251
Homepage URL
kmurakami@gesurg.med.osaka-u.ac.jp
Sponsor or person
Institute
Osaka University School of Medicine Gastroenterological Surgery
Institute
Department
Personal name
Funding Source
Organization
Osaka University School of Medicine Gastroenterological Surgery
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2013 | Year | 05 | Month | 21 | Day |
Related information
URL releasing protocol
Publication of results
Published
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
De-acylation activity was lower in liver failure patients, which could cause elevation of AG levels. Serum cholinesterase may be responsible for de-acylation in humans.
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2012 | Year | 10 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2013 | Year | 05 | Month | 21 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Evaluate the ghrelin and liver function before and after treatment, to consider their association
Management information
Registered date
| 2013 | Year | 05 | Month | 21 | Day |
Last modified on
| 2015 | Year | 06 | Month | 18 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012598
